Blossom Receives Pre-License from Infarmed to Manufacture Cannabis Products — Blossom, a leading name in pharmaceutical contract manufacturing, is pleased to announce that it has received its pre-license from Infarmed, the Portuguese National Authority of Medicines and Health Products, to manufacture cannabis-based products for medical and recreational use.
This marks a significant milestone for Blossom, enabling the company to expand its product range and pave the way for new research and development initiatives in the cannabis sector.
Setting Standards in Compliance and Safety
The pre-license is the result of rigorous compliance and safety checks, ensuring Blossom adheres to the highest standards for cultivation, manufacturing, and distribution of cannabis products. This validates Blossom’s commitment to product excellence, consumer safety, and regulatory compliance.
A Step Towards Comprehensive Well-being "Receiving the pre-license from Infarmed is a significant achievement for Blossom and aligns perfectly with our vision to offer comprehensive contract manufacturing solutions," said Oskar Fletcher, CEO of Blossom. "We're excited about the possibilities this opens up for us in both local and international markets. From medical applications to a range of consumer products, the cannabis sector offers a promising avenue to diversify and expand."
A Future-Ready Company Blossom plans to invest in state-of-the-art infrastructure, a dedicated R&D division, and the expansion of its product line.
About Blossom Established in 2019 Blossom is a specialised contract manufacturer in the medical cannabis industry. The company focuses on providing turnkey solutions for businesses looking to produce a wide range of medical cannabis products. With a commitment to quality, compliance, and customer satisfaction, Blossom has quickly become a trusted name in cannabis contract manufacturing.
Infarmed, the Portuguese National Authority of Medicines and Health Products, is responsible for the evaluation, authorization, regulation, and control of medicines, medical devices, and health products in Portugal to ensure their quality, effectiveness, and safety for public consumption.